Synagis: payments to doctors
Payments that named Synagis as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 13,247
- Transactions
- 25,752
- Average per transaction
- $51
The per-transaction average — $51 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,247 providers the average total is $99, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sobi, Inc | $748,107 | 56.8% |
| SOBI, Inc | $554,410 | 42.1% |
| Swedish Orphan Biovitrum AB | $15,389 | 1.2% |